968 / 1084
Analysis of
combination chemotherapy versus single agent
, mainly fluorouracil (FU) -based
chemotherapy (HR 0.83; 95% CI 0.74 to 0.93) showed
significant overall survival benefits in favor of
combination chemotherapy
03/28/2017